Biocon Q3 Results

  • BSE: 532523
  • NSE: BIOCON
  • ISIN: INE376G01013
  • Sector: Biotechnology & Drugs
BSE
336.355.15 (1.55%)
Volume46.91 K
Updated: Mon 25 Nov, 2024 | 15:29:37
NSE
336.354.85 (1.46%)
Volume1.45 M
Updated: Mon 25 Nov, 2024 | 15:44:41
Today: 333.65
338.90
52-Wk: 231.35
395.65

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Biocon Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 3,953.703,462.30-%2,941.10-%
    Selling/ General/ Admin Expenses Total 720.80622.40-%558.80-%
    Depreciation/ Amortization 414.50389.30-%301.10-%
    Other Operating Expenses Total 1,074.30971.30-%758.40-%
    Total Operating Expense 3,389.503,134.00-%2,869.30-%
    Operating Income 564.20328.30-%71.80-%
    Net Income Before Taxes 808.20214.30-%-25.50-%
    Net Income 660.00125.60-%-41.80-%
    Diluted Normalized EPS 5.111.21-%1.13-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts